Latest news releases

View all releases

Vaccines deliver over US$ 30 billion in economic benefits for lower-income countries in 2025

Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations.

Made in Africa: New measles rapid diagnostic tests mark breakthrough for vaccination efforts

First-of-their-kind rapid measles diagnostic tests will support targeted vaccination during outbreaks and identification of priorities for preventive vaccination efforts.

Gavi for the media

Gavi for the media

Visit our dedicated media room to see our latest press releases and statements, updated key facts and figures, as well as contact details for our media team.

Gavi/Frederique Tissandier

Latest publications

View all reports

Gavi Progress Report 2024

Welcome to Gavi’s 2024 Annual Progress Report, the fourth of the 2021–2025 strategic period.

Gavi Progress Report 2023

Welcome to Gavi’s 2023 Annual Progress Report, the third of the 2021–2025 strategic period.

Last updated: 18 Feb 2026